<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Innov Aging</journal-id><journal-id journal-id-type="iso-abbrev">Innov Aging</journal-id><journal-id journal-id-type="publisher-id">innovateage</journal-id><journal-title-group><journal-title>Innovation in Aging</journal-title></journal-title-group><issn pub-type="epub">2399-5300</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6840926</article-id><article-id pub-id-type="doi">10.1093/geroni/igz038.047</article-id><article-id pub-id-type="publisher-id">igz038.047</article-id><article-categories><subj-group subj-group-type="heading"><subject>Session 545 (Symposium)</subject></subj-group></article-categories><title-group><article-title>USE OF NEW HEPATITIS C DRUGS IN MEDICARE: PERSISTENT URBAN-RURAL DISPARITIES AND POTENTIAL INTERVENTIONS</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Du</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib></contrib-group><aff id="AF0001">
<institution>Pennsylvania State University College of Medicine</institution>, Hershey, Pennsylvania, <country country="US">United States</country></aff><pub-date pub-type="collection"><month>11</month><year>2019</year></pub-date><pub-date pub-type="epub" iso-8601-date="2019-11-08"><day>08</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>08</day><month>11</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>3</volume><issue>Suppl 1</issue><issue-title>Program Abstracts from the GSA 2019 Annual Scientific Meeting &#x0201c;Strength in Age&#x02014;Harnessing the Power of Networks&#x0201d;</issue-title><fpage>S13</fpage><lpage>S13</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America.</copyright-statement><copyright-year>2019</copyright-year><license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="igz038.047.pdf"/><abstract><title>Abstract</title><p>Chronic hepatitis C virus (HCV) infection, whose prevalence is concentrated among older adults, can bring serious health impacts and high financial burden. With the availability of highly effective and well tolerated direct-acting antiviral (DAA) therapy, treatment of chronic HCV infection has rapidly evolved, making HCV treatment less burdensome. However, the high cost of DAA and lack of clinical expertise are still important barriers for providing DAA therapy to rural patients, highlighting the urban-rural disparities in managing many chronic diseases for aging populations. Telehealth could serve as effective care-model to improve management of HCV infection for older, rural populations. This talk will present work that examines multi-level factors affecting HCV DAA treatment (focusing on urban-rural disparities), evaluates changes in urban-rural disparities in DAA utilization over time, and explores the role of a telehealth-based intervention in reducing urban-rural disparities in HCV DAA treatment in Medicare patients. </p></abstract><counts><page-count count="1"/></counts></article-meta></front></article>